微生物细胞制造的乙肝病毒抗原有免疫作用，可抵御病毒感染。
Hepatitis B virus antigens made in microbial cells immunise against viral infection.
作者信息
Murray K, Bruce S A, Hinnen A, Wingfield P, van Erd P M, de Reus A, Schellekens H
出版信息
EMBO J. 1984 Mar;3(3):645-50. doi: 10.1002/j.1460-2075.1984.tb01861.x.
Abstract
Chimpanzees have been vaccinated successfully against hepatitis B virus with preparations of the viral antigens made in microbial cells by genetic engineering methods.
摘要
通过基因工程方法利用微生物细胞制备的病毒抗原制剂已成功使黑猩猩接种了乙肝疫苗。
相似文献
1
Hepatitis B virus antigens made in microbial cells immunise against viral infection.
EMBO J. 1984 Mar;3(3):645-50. doi: 10.1002/j.1460-2075.1984.tb01861.x.
2
Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
J Infect Dis. 1983 Feb;147(2):327-35. doi: 10.1093/infdis/147.2.327.
3
The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
Postgrad Med J. 1987;63 Suppl 2:93-6.
4
Human hepatitis B vaccine from recombinant yeast.
Nature. 1984;307(5947):178-80. doi: 10.1038/307178a0.
5
Immunisation against hepatitis B in man.
Lancet. 1976 Jun 26;1(7974):1367-70. doi: 10.1016/s0140-6736(76)93023-3.
6
Hepatitis-B vaccine. Safety criteria and non-B infection.
Lancet. 1976 Jun 26;1(7974):1396-7. doi: 10.1016/s0140-6736(76)93039-7.
7
Immunization against hepatitis B. A new era in prevention.
CDA J. 1982 Oct;10(10):29-35.
8
A new hepatitis B vaccine containing HBeAg in addition to HBsAg.
Dev Biol Stand. 1983;54:13-22.
9
Protective immunisation against hepatitis B with an internal antigen of the virus.
J Med Virol. 1987 Oct;23(2):101-7. doi: 10.1002/jmv.1890230202.
10
Safety of hepatitis-B vaccines containing intact 20 nm particles.
Lancet. 1979 Mar 3;1(8114):488. doi: 10.1016/s0140-6736(79)90836-5.
引用本文的文献
1
PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.
Microorganisms. 2023 Apr 8;11(4):972. doi: 10.3390/microorganisms11040972.
2
Microparticles and Nanoparticles from Plants-The Benefits of Bioencapsulation.
Vaccines (Basel). 2021 Apr 11;9(4):369. doi: 10.3390/vaccines9040369.
3
Inflammasomes as Targets for Adjuvants.
Pathogens. 2020 Mar 30;9(4):252. doi: 10.3390/pathogens9040252.
4
Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain.
Neurobiol Aging. 2018 Mar;63:12-21. doi: 10.1016/j.neurobiolaging.2017.10.019. Epub 2017 Nov 1.
5
Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.
J Biol Chem. 2017 Oct 6;292(40):16760-16772. doi: 10.1074/jbc.M117.802272. Epub 2017 Aug 23.
6
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.
Stud Hist Philos Biol Biomed Sci. 2017 Aug;64:11-21. doi: 10.1016/j.shpsc.2017.05.004. Epub 2017 May 13.
7
Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
Appl Environ Microbiol. 2015 Feb;81(3):882-9. doi: 10.1128/AEM.03695-14. Epub 2014 Nov 21.
8
Phage display creates innovative applications to combat hepatitis B virus.
World J Gastroenterol. 2014 Sep 7;20(33):11650-70. doi: 10.3748/wjg.v20.i33.11650.
9
Easing the global burden of diarrhoeal disease: can synthetic biology help?
Syst Synth Biol. 2013 Sep;7(3):73-8. doi: 10.1007/s11693-013-9114-6. Epub 2013 Jul 20.
10
Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein.
Viral Immunol. 2007 Spring;20(1):56-65. doi: 10.1089/vim.2006.0053.
本文引用的文献
1
A sensitive immunoradiometric assay for the detection of hepatitis B surface antigen.
J Virol Methods. 1980;1(6):311-23. doi: 10.1016/0166-0934(80)90048-8.
2
Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.
Ann Intern Med. 1982 Sep;97(3):367-9. doi: 10.7326/0003-4819-97-3-367.
3
Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy.
J Med Virol. 1982;9(2):139-48. doi: 10.1002/jmv.1890090209.
4
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.
Nature. 1982 Jul 22;298(5872):347-50. doi: 10.1038/298347a0.
5
Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1606-10. doi: 10.1073/pnas.79.5.1606.
6
The conversion of hepatitis B core antigen synthesized in E coli into e antigen.
J Med Virol. 1981;8(4):237-43. doi: 10.1002/jmv.1890080404.
7
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
N Engl J Med. 1980 Oct 9;303(15):833-41. doi: 10.1056/NEJM198010093031501.
8
Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA.
Proc Natl Acad Sci U S A. 1982 Mar;79(6):1815-9. doi: 10.1073/pnas.79.6.1815.
9
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4549-53. doi: 10.1073/pnas.77.8.4549.
10
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers.
J Infect Dis. 1983 Mar;147(3):531-4. doi: 10.1093/infdis/147.3.531.
Zotero 插件